A-KINE Trademark

Trademark Overview


On Friday, January 3, 2020, a trademark application was filed for A-KINE with the United States Patent and Trademark Office. The USPTO has given the A-KINE trademark a serial number of 88746472. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Orionis Biosciences Inc.. The A-KINE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases

Diagnostic and biological reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
a-kine

General Information


Serial Number88746472
Word MarkA-KINE
Filing DateFriday, January 3, 2020
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7157673
Registration DateTuesday, September 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements


Goods and ServicesPharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases
Goods and ServicesDiagnostic and biological reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code001
First Use Anywhere DateTuesday, September 13, 2022
First Use In Commerce DateTuesday, September 13, 2022

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code005
First Use Anywhere DateFriday, June 2, 2023
First Use In Commerce DateFriday, June 2, 2023

Trademark Owner History


Party NameOrionis Biosciences Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameOrionis Biosciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameOrionis Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 30, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, June 23, 2023USE AMENDMENT FILED
Friday, June 23, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, December 7, 2022SOU EXTENSION 5 FILED
Wednesday, December 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2022SOU EXTENSION 4 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 4 FILED
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 3 FILED
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 2 GRANTED
Monday, June 14, 2021SOU EXTENSION 2 FILED
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 24, 2020ASSIGNED TO EXAMINER
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 7, 2020NEW APPLICATION ENTERED